Terms: = Breast cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Prognosis
20 results:
1. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
2. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort.
Hu Y; Mao L; Wang M; Li Z; Li M; Wang C; Ji L; Zeng H; Zhang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7285-7297. PubMed ID: 36917189
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
4. Genetic co-expression networks contribute to creating predictive model and exploring novel biomarkers for the prognosis of breast cancer.
Li YK; Hsu HM; Lin MC; Chang CW; Chu CM; Chang YJ; Yu JC; Chen CT; Jian CE; Sun CA; Chen KH; Kuo MH; Cheng CS; Chang YT; Wu YS; Wu HY; Yang YT; Lin C; Lin HC; Hu JM; Chang YT
Sci Rep; 2021 Mar; 11(1):7268. PubMed ID: 33790307
[TBL] [Abstract] [Full Text] [Related]
5. FGFR1 Is Associated With Tamoxifen Resistance and Poor prognosis of ER-Positive breast cancers by Suppressing ER Protein Expression.
Lv Q; Guan S; Zhu M; Huang H; Wu J; Dai X
Technol Cancer Res Treat; 2021; 20():15330338211004935. PubMed ID: 33783288
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
Peng Y; Shui L; Xie J; Liu S
J Cell Mol Med; 2020 Aug; 24(16):9378-9387. PubMed ID: 32649035
[TBL] [Abstract] [Full Text] [Related]
7. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract] [Full Text] [Related]
8. Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy.
Liao Y; Liao Y; Li J; Xiong J; Fan Y
Sci Rep; 2020 Apr; 10(1):7349. PubMed ID: 32355298
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis.
Li C; Fan H; Xiang Q; Xu L; Zhang Z; Liu Q; Zhang T; Ling J; Zhou Y; Zhao X; Cui Y
Breast Cancer Res Treat; 2019 Dec; 178(3):497-504. PubMed ID: 31471838
[TBL] [Abstract] [Full Text] [Related]
10. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract] [Full Text] [Related]
11. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract] [Full Text] [Related]
12. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract] [Full Text] [Related]
13. breast cancer subtype and survival by parity and time since last birth.
De Mulder H; Laenen A; Wildiers H; Punie K; Poppe A; Remmerie C; Lefrère H; Nevelsteen I; Smeets A; Van Nieuwenhuysen E; Han S; Van Limbergen E; Floris G; Vergote I; Neven P
Breast Cancer Res Treat; 2018 Jun; 169(3):481-487. PubMed ID: 29426984
[TBL] [Abstract] [Full Text] [Related]
14. The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang F; Wang D; Ma L; Zhou L; Han D
Oncotarget; 2016 Jun; 7(24):36655-36665. PubMed ID: 27166269
[TBL] [Abstract] [Full Text] [Related]
15. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
Wang H; Wang X; Wang C
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
[TBL] [Abstract] [Full Text] [Related]
16. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract] [Full Text] [Related]
17. Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.
Liu M; Yang YJ; Zheng H; Zhong XR; Wang Y; Wang Z; Wang YG; Wang YP
Oncol Rep; 2014 Dec; 32(6):2619-27. PubMed ID: 25241923
[TBL] [Abstract] [Full Text] [Related]
18. Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.
Thike AA; Yong-Zheng Chong L; Cheok PY; Li HH; Wai-Cheong Yip G; Huat Bay B; Tse GM; Iqbal J; Tan PH
Mod Pathol; 2014 Mar; 27(3):352-60. PubMed ID: 23929266
[TBL] [Abstract] [Full Text] [Related]
19. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
[TBL] [Abstract] [Full Text] [Related]
